Sharin E. Roth
Impact in
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
-
- Genetic and Kidney Cyst Diseases
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 6
- Genetics 3
- Genetic and Kidney Cyst Diseases 3
- Co-authors
- William J. Brock (6 shared papers)Merrie Mosedale (5 shared papers)Paul Brent Watkins (4 shared papers)Kim L. R. Brouwer (4 shared papers)Rachel J. Church (2 shared papers)J. Scott Eaddy (2 shared papers)James J. Beaudoin (3 shared papers)Vicente E. Torres (2 shared papers)
- Journals
- Toxicological Sciences (4 papers)Drug Metabolism and Disposition (2 papers)Clinical Pharmacology & Therapeutics (1 paper)American Journal of Kidney Diseases (1 paper)Journal of Chromatography B (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Sharin E. Roth
13 papers receiving 342 citations
Peers
Comparison fields: 5 of 33
- Pharmacology 135
- Genetics 53
- Toxicology 6
- Nephrology 13
- Analytical Chemistry 8
Countries citing papers authored by Sharin E. Roth
This map shows the geographic impact of Sharin E. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharin E. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharin E. Roth more than expected).
Fields of papers citing papers by Sharin E. Roth
This network shows the impact of papers produced by Sharin E. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharin E. Roth. The network helps show where Sharin E. Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharin E. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 80 | |
| 2 | 2017 | 42 | |
| 3 | 2016 | 41 | |
| 4 | 2019 | 35 | |
| 5 | 2022 | 29 | |
| 6 | 2019 | 28 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2018 | 13 | |
| 11 | 2009 | 12 | |
| 12 | 2015 | 12 | |
| 13 | 2020 | 10 |
About Sharin E. Roth
Sharin E. Roth is a scholar working on Pharmacology, Genetics, Analytical Chemistry, Oncology and Nuclear Energy and Engineering, having authored 13 papers that have together received 352 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (6 papers), Genetic and Kidney Cyst Diseases (3 papers), Analytical Methods in Pharmaceuticals (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Pharmacology (135 citations), Genetics (53 citations), Toxicology (6 citations), Nephrology (13 citations) and Analytical Chemistry (8 citations). Sharin E. Roth has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include William J. Brock, Merrie Mosedale, Paul Brent Watkins, Kim L. R. Brouwer, Rachel J. Church, J. Scott Eaddy, James J. Beaudoin, Vicente E. Torres, Linsey Stiles and Brett A. Howell. Their work appears in journals such as Toxicological Sciences, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, American Journal of Kidney Diseases and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.